Similarly, ATF3 expression was remarkably upregulated in liver samples derived from patients with NASH and MAFLD model mice (Fig. 1i, j, Supplementary Fig. 1g, h). The gene discussed is ATF3; the disease is metabolic dysfunction-associated steatohepatitis.